Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Market Cap	6.06B -35.2%
Revenue (ttm)	1.95B +2.5%
Net Income	106.47M -25.7%
EPS	0.18 -32.2%
Shares Out	571.39M
PE Ratio	59.96
Forward PE	30.29
Dividend	0.02 (0.20%)
Ex-Dividend Date	Jun 12, 2026

Volume	7,201,404
Open	10.74
Previous Close	10.79
Day's Range	10.55 - 10.98
52-Week Range	8.34 - 17.00
Beta	0.26
Analysts	Strong Buy
Price Target	16.01 (+51.04%)
Earnings Date	Oct 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. It offers chemiluminescence immunoassay analyzer, diabetes instruments and related reagents, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,689
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688575

Financial Performance

In 2025, Shenzhen YHLO Biotech's revenue was 1.81 billion, a decrease of -9.99% compared to the previous year's 2.01 billion. Earnings were 23.34 million, a decrease of -92.26%.

Analyst Summary

According to 5 analysts, the average rating for 688575 stock is "Strong Buy." The 12-month stock price target is ¥16.01, which is an increase of 51.04% from the latest price.

Price Target

¥16.01

(51.04% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error